These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9279980)
1. Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone. Edstein MD; Looareesuwan S; Viravan C; Kyle DE Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):216-20. PubMed ID: 9279980 [TBL] [Abstract][Full Text] [Related]
2. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Hussein Z; Eaves J; Hutchinson DB; Canfield CJ Clin Pharmacol Ther; 1997 May; 61(5):518-30. PubMed ID: 9164414 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand. Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165 [TBL] [Abstract][Full Text] [Related]
5. Atovaquone-proguanil for prophylaxis and treatment of malaria. Marra F; Salzman JR; Ensom MH Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511 [TBL] [Abstract][Full Text] [Related]
6. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090 [TBL] [Abstract][Full Text] [Related]
7. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569 [TBL] [Abstract][Full Text] [Related]
8. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro. Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371 [TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL; Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597 [TBL] [Abstract][Full Text] [Related]
13. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852 [TBL] [Abstract][Full Text] [Related]
14. [New strategies in therapy to roll back malaria]. Kaiser A; Maier W Dtsch Med Wochenschr; 2002 Jul; 127(30):1595-600. PubMed ID: 12143016 [No Abstract] [Full Text] [Related]
15. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139 [No Abstract] [Full Text] [Related]
16. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Sabchareon A; Attanath P; Phanuaksook P; Chanthavanich P; Poonpanich Y; Mookmanee D; Chongsuphajaisiddhi T; Sadler BM; Hussein Z; Canfield CJ; Hutchinson DB Trans R Soc Trop Med Hyg; 1998; 92(2):201-6. PubMed ID: 9764334 [TBL] [Abstract][Full Text] [Related]
17. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Patel SN; Kain KC Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498 [TBL] [Abstract][Full Text] [Related]
18. [What is the value of the combination atovaquone-proguanil for the clinician?]. Delmont J Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917 [TBL] [Abstract][Full Text] [Related]
19. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183 [TBL] [Abstract][Full Text] [Related]
20. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris]. Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]